How Does Teva Pharmaceutical Industries Ltd (TEVA) Stock Stack Up in the Healthcare Sector?

Thursday, February 13, 2020 11:13 AM | InvestorsObserver Analysts

Teva Pharmaceutical Industries Ltd (TEVA) is near the top in its sector according to InvestorsObserver.

TEVA gets an overall rating of 47. That means it scores higher than 47% of stocks.

Teva Pharmaceutical Industries Ltd gets a 55 rank in the Healthcare sector. Healthcare is number 7 out of 11 sectors.

Overall Score - 47
TEVA has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on TEVA!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector.

Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score.

The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.)

What's Happening With Teva Pharmaceutical Industries Ltd Stock Today?

Teva Pharmaceutical Industries Ltd (TEVA) stock is trading at $12.86 as of 10:58 AM on Thursday, Feb 13, a loss of -$0.59, or -4.39% from the previous closing price of $13.45. The stock has traded between $12.72 and $13.39 so far today. Volume today is light. So far 10,083,150 shares have traded compared to average volume of 19,440,608 shares.

To screen for more stocks like TEVA click here.

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium

InvestorsObserver Premium

$ 16.58 $ 8.29 /month
$199 $99.50 billed annually

Related Articles

Related Companies